- This strategic addition expands ERBC Group's non-clinical derisking capabilities to include efficacy, biodistribution, mechanistic and proof of concept studies based on in vitro and in vivo models…
- Corporate news
- Corporate newsETISENSE (Lyon) and the EUROPEAN RESEARCH BIOLOGY CENTER (ERBC Group) announce a collaboration to develop and validate the DECRO telemetry solution for marmosets, a new world primate with several…
- Corporate newsThis strategic acquisition expands ERBC Group’s non-clinical research and development testing portfolio, adding in ovo models for anticancer drug development. Baugy, France, January 18th 2023 –…
- Corporate newsUI Investissement, alongside MACSF, is supporting the development of ERBC Group, specialized in non-clinical research performing the evaluation of drug candidates for pharmaceutical and biotechnology…
- EventERBC (European Research Biology Center) and our partners Oncodesign, CYNBIOSE and PharmaLex a.r.c., presented a Digital Workshop “How do we keep you in the race of COVID19 ?“ during BioFIT 2020. Did…
- Corporate newsERBC, Oncodesign, Cynbiose, Aepodia and PharmaLex a.r.c. and Belgium are pleased to announce the signature of a partnering agreement to provide the biotech and pharma industry with a full-service…